Persistent depressive symptoms, HPA-axis hyperactivity, and inflammation: the role of cognitive-affective and somatic symptoms

Molecular Psychiatry - Tập 25 Số 5 - Trang 1130-1140 - 2020
Eleonora Iob1, Clemens Kirschbaum2, Andrew Steptoe1
1Department of Behavioural Science and Health, University College London, London, UK
2Department of Psychology, Technische Universität Dresden, Dresden, Germany

Tóm tắt

Abstract

Hypothalamic-pituitary-adrenal (HPA)-axis hyperactivity and inflammation are thought to be prominent in the aetiology of depression. Although meta-analyses have confirmed this relationship, there is considerable variability in the effect sizes across studies. This could be attributed to a differential role of such biological systems in somatic versus cognitive-affective depressive symptoms which remains largely unexplored. Furthermore, most longitudinal research to date has focused on transient rather than persistent depressive symptoms. In the current study, we investigated the associations of hair cortisol and plasma C-reactive protein (CRP) with the longitudinal persistence and dimensions (cognitive-affective versus somatic) of depressive symptoms over a 14-year period using Trait‐State‐Occasion (TSO) structural equation modelling. The data came from a large sample of older adults from the English Longitudinal Study of Ageing. Depressive symptoms were assessed from wave 1 (2002–03) to wave 8 (2016–17). Hair cortisol (N = 4761) and plasma CRP (N = 5784) were measured in wave 6 (2012–13). Covariates included demographic, socioeconomic, lifestyle, chronic disease, and medication data. Our results revealed that higher cortisol and CRP levels were significantly associated with persistent depressive symptoms across the study period. Notably, both biomarkers exhibited stronger relationships with somatic than with cognitive-affective symptoms. The associations with somatic symptoms were also independent of relevant confounding factors. In contrast, their associations with cognitive-affective symptoms were weak after adjustment for all covariates. These distinct associations reveal the importance of considering symptom-specific effects in future studies on pathophysiological mechanisms. Ultimately, this will have the potential to advance the search for biomarkers of depression and facilitate more targeted treatments.

Từ khóa


Tài liệu tham khảo

American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. Washington, DC: APA; 2013.

World Health Organization. The ICD-10 classification of mental and behavioural disorders. 1992. https://www.who.int/classifications/icd/en/bluebook.pdf.

Hammen C. Stress and depression. Annu Rev Clin Psychol. 2005;1:293–319.

Kendler KS, Karkowski LM, Prescott CA. Causal relationship between stressful life events and the onset of major depression. Am J Psychiatry. 1999;156:837–41.

Cuijpers P, Vogelzangs N, Twisk J, Kleiboer A, Li J, Penninx BW. Comprehensive meta-analysis of excess mortality in depression in the general community versus patients with specific illnesses. Am J Psychiatry. 2014;171:453–62.

Nicholson A, Kuper H, Hemingway H. Depression as an aetiologic and prognostic factor in coronary heart disease: a meta-analysis of 6362 events among 146,538 participants in 54 observational studies. Eur Heart J. 2006;27:2763–74.

Steptoe A. Depression and negative emotions. In: Kivimäki M, Batty GD, Steptoe A, Kawachi I, editors. The Routledge international handbook of psychosocial epidemiology. London: Routledge; 2017. p.136–55.

Prasad S, Sung B, Aggarwal BB. Age-associated chronic diseases require age-old medicine: role of chronic inflammation. Prev Med. 2012;54:S29–37.

Jeon H-S, Dunkle RE. Stress and depression among the oldest-old: a longitudinal analysis. Res Aging. 31:661–87.

Rodda J, Walker Z, Carter J. Depression in older adults. BMJ. 2011;343:d5219–d5219.

Malhi GS, Mann JJ. Depression. Lancet. 2018;392:2299–312.

McEwen BS. Physiology and neurobiology of stress and adaptation: central role of the brain. Physiol Rev. 2007;87:873–904.

Iob E, Kirschbaum C, Steptoe A. Positive and negative social support and HPA-axis hyperactivity: Evidence from glucocorticoids in human hair. Psychoneuroendocrinology. 2018;96:100–8.

Rohleder N. Stimulation of systemic low-grade inflammation by psychosocial stress. Psychosom Med. 2014;76:181–9.

Calcia MA, Bonsall DR, Bloomfield PS, Selvaraj S, Barichello T, Howes OD. Stress and neuroinflammation: a systematic review of the effects of stress on microglia and the implications for mental illness. Psychopharmacol. 2016;233:1637–50.

Stetler C, Miller GE. Depression and hypothalamic-pituitary-adrenal activation: a quantitative summary of four decades of research. Psychosom Med. 2011;73:114–26.

Haapakoski R, Mathieu J, Ebmeier KP, Alenius H, Kivimäki M. Cumulative meta-analysis of interleukins 6 and 1β, tumour necrosis factor α and C-reactive protein in patients with major depressive disorder. Brain Behav Immun. 2015;49:206–15.

Girod J, Brotman D. Does altered glucocorticoid homeostasis increase cardiovascular risk? Cardiovasc Res. 2004;64:217–26.

Hackett RA, Kivimäki M, Kumari M, Steptoe A. Diurnal cortisol patterns, future diabetes, and impaired glucose metabolism in the Whitehall II cohort study. J Clin Endocrinol Metab. 2016;101:619–25.

Jackson SE, Kirschbaum C, Steptoe A. Hair cortisol and adiposity in a population-based sample of 2,527 men and women aged 54 to 87 years. Obesity. 2017;25:539–44.

Acabchuk RL, Kamath J, Salamone JD, Johnson BT. Stress and chronic illness: the inflammatory pathway. Soc Sci Med. 2017;185:166–70.

Dowlati Y, Herrmann N, Swardfager W, Liu H, Sham L, Reim EK, et al. A meta-analysis of cytokines in major depression. Biol Psychiatry. 2010;67:446–57.

Knorr U, Vinberg M, Kessing LV, Wetterslev J. Salivary cortisol in depressed patients versus control persons: a systematic review and meta-analysis. Psychoneuroendocrinology. 2010;35:1275–86.

Lamers F, Vogelzangs N, Merikangas KR, De Jonge P, Beekman ATF, Penninx BWJH. Evidence for a differential role of HPA-axis function, inflammation and metabolic syndrome in melancholic versus atypical depression. Mol Psychiatry. 2013;18:692–9.

Fried EI, Nesse RM. Depression sum-scores don’t add up: why analyzing specific depression symptoms is essential. BMC Med. 2015;13:1–12.

Jentsch MC, Van Buel EM, Bosker FJ, Gladkevich AV, Klein HC, Oude Voshaar RC, et al. Biomarker approaches in major depressive disorder evaluated in the context of current hypotheses. Biomark Med. 2015;9:277–97.

Shafer AB. Meta-analysis of the factor structures of four depression questionnaires: Beck, CES-D, Hamilton, and Zung. J Clin Psychol. 2006;62:123–46.

Dantzer R. Neuroimmune Interactions: from the brain to the immune system and vice versa. Physiol Rev. 2018;98:477–504.

Dantzer R, O’Connor JC, Freund GG, Johnson RW, Kelley KW. From inflammation to sickness and depression: when the immune system subjugates the brain. Nat Rev Neurosci. 2008;9:46–56.

Miller AH, Maletic V, Raison CL. Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression. Biol Psychiatry. 2009;65:732–41.

White J, Kivimäki M, Jokela M, Batty GD. Association of inflammation with specific symptoms of depression in a general population of older people: the English longitudinal study of ageing. Brain Behav Immun. 2017;61:27–30.

Jokela M, Virtanen M, Batty GD, Kivimäki M. Inflammation and specific symptoms of depression. JAMA Psychiatry. 2016;73:87–8.

Duivis HE, Vogelzangs N, Kupper N, de Jonge P, Penninx BWJH. Differential association of somatic and cognitive symptoms of depression and anxiety with inflammation: findings from the Netherlands Study of Depression and Anxiety (NESDA). Psychoneuroendocrinology. 2013;38:1573–85.

Chu AL, Stochl J, Lewis G, Zammit S, Jones PB, Khandaker GM. Longitudinal association between inflammatory markers and specific symptoms of depression in a prospective birth cohort. Brain Behav Immun. 2019;76:74–81.

Bosch NM, Riese H, Dietrich A, Ormel J, Verhulst FC, Oldehinkel AJ. Preadolescents’ somatic and cognitive-affective depressive symptoms are differentially related to cardiac autonomic function and cortisol: the TRAILS study. Psychosom Med. 2009;71:944–50.

Davey A, Halverson CF, Zonderman AB, Costa PT. Change in depressive symptoms in the Baltimore longitudinal study of aging. J Gerontol Ser B. 2004;59:P270–7.

Glymour MM, Kubzansky LD. Causal inference in psychosocial epidemiology. In: Kivimäki M, Batty GD, Steptoe A, Kawachi I, editors. The Routledge international handbook of psychosocial epidemiology. London: Routledge; 2017. p. 21–45.

Khandaker GM, Stochl J, Zammit S, Goodyer I, Lewis G, Jones PB. Childhood inflammatory markers and intelligence as predictors of subsequent persistent depressive symptoms: a longitudinal cohort study. Psychol Med. 2018;48:1514–22.

Cole DA. Coping with longitudinal data in research on developmental psychopathology. Int J Behav Dev. 2006;30:20–5.

Steptoe A, Breeze E, Banks J, Nazroo J. Cohort Profile: the English longitudinal study of ageing. Int J Epidemiol. 2013;42:1640–8.

Natcen Social Research. ELSA user guide to the main interview datasets, Waves 1 to 8. London, 2018. http://doc.ukdataservice.ac.uk/doc/5050/mrdoc/pdf/5050_waves_1-8_interviewer_data_user_guide_v01.pdf.

Radloff LS. The CES-D scale. Appl Psychol Meas. 1977;1:385–401.

Radloff LS. The CES-D scale: a self-report depression scale for research in the general population. Appl Psychol Meas. 1977;1:385–401.

Andresen EM, Malmgren JA, Carter WB, Patrick DL. Screening for depression in well older adults: evaluation of a short form of the CES-D (center for epidemiologic studies depression scale). Am J Prev Med. 1994;10:77–84.

Kirschbaum C, Tietze A, Skoluda N, Dettenborn L. Hair as a retrospective calendar of cortisol production—increased cortisol incorporation into hair in the third trimester of pregnancy. Psychoneuroendocrinology. 2009;34:32–7.

Gao W, Stalder T, Foley P, Rauh M, Deng H, Kirschbaum C. Quantitative analysis of steroid hormones in human hair using a column-switching LC-APCI-MS/MS assay. J Chromatogr B Analyt Technol Biomed Life Sci. 2013;928:1–8.

Lassale C, Batty GD, Steptoe A, Cadar D, Akbaraly TN, Kivimäki M, et al. Association of 10-year C-reactive protein trajectories with markers of healthy aging: findings from the English longitudinal study of aging. J Gerontol Ser A. 2018;74:195–203.

NatCen Social Research. English longitudinal study of ageing (ELSA): user guide to the nurse visit datasets. Waves 2, 4, 6, 8. 2018.

Newsom JT. Longitudinal structural equation modeling. New York: Taylor & Francis; 2015.

Asparouhov T, Muthén B. Weighted least squares estimation with missing data. 2010. http://www.statmodel.com/download/GstrucMissingRevision.pdf. Accessed 10 Jan 2019.

Prenoveau JM. Specifying and interpreting latent state–trait models with autoregression: an illustration. Struct Equ Model. 2016;23:731–49.

Adam EK, Kumari M. Assessing salivary cortisol in large-scale, epidemiological research. Psychoneuroendocrinology. 2009;34:1423–36.

Soria V, González-Rodríguez A, Huerta-Ramos E, Usall J, Cobo J, Bioque M, et al. Targeting hypothalamic-pituitary-adrenal axis hormones and sex steroids for improving cognition in major mood disorders and schizophrenia: a systematic review and narrative synthesis. Psychoneuroendocrinology. 2018;93:8–19.

Harrison NA, Brydon L, Walker C, Gray MA, Steptoe A, Critchley HD. Inflammation causes mood changes through alterations in subgenual cingulate activity and mesolimbic connectivity. Biol Psychiatry. 2009;66:407–14.

Köhler O, Benros ME, Nordentoft M, Farkouh ME, Iyengar RL, Mors O, et al. Effect of anti-inflammatory treatment on depression, depressive symptoms, and adverse effects. JAMA Psychiatry. 2014;71:1381–91.

Kappelmann N, Lewis G, Dantzer R, Jones PB, Khandaker GM. Antidepressant activity of anti-cytokine treatment: a systematic review and meta-analysis of clinical trials of chronic inflammatory conditions. Nat Publ Gr. 2016;23:335–43.

Eachus H, Cunliffe VT. Biological embedding of psychosocial stress over the life course. Epigenetics Aging Longev. 2018;4:251–70.

Zahodne LB, Gilsanz P, Glymour MM, Gibbons LE, Brewster P, Hamilton J, et al. Comparing variability, severity, and persistence of depressive symptoms as predictors of future stroke risk. Am J Geriatr Psychiatry. 2017;25:120–8.

Dietrich A, Ormel J, Buitelaar JK, Verhulst FC, Hoekstra PJ, Hartman CA. Cortisol in the morning and dimensions of anxiety, depression, and aggression in children from a general population and clinic-referred cohort: an integrated analysis. The TRAILS study. Psychoneuroendocrinology. 2013;38:1281–98.

Stalder T, Kirschbaum C. Analysis of cortisol in hair —state of the art and future directions. Brain Behav Immun. 2012;26:1019–29.

Capuron L, Gumnick JF, Musselman DL, Lawson DH, Reemsnyder A, Nemeroff CB, et al. Neurobehavioral effects of interferon-α in cancer patients phenomenology and paroxetine responsiveness of symptom dimensions. Neuropsychopharmacology. 2002;26:643–52.

Brydon L, Harrison NA, Walker C, Steptoe A, Critchley HD. Peripheral inflammation is associated with altered substantia nigra activity and psychomotor slowing in humans. Biol Psychiatry. 2008;63:1022–9.

De La Garza R. Endotoxin- or pro-inflammatory cytokine-induced sickness behavior as an animal model of depression: focus on anhedonia. Neurosci Biobehav Rev. 2005;29:761–70.

Hughes MM, Connor TJ, Harkin A. Stress-related immune markers in depression: implications for treatment. Int J Neuropsychopharmacol. 2016;19:pyw001.

Jha MK, Minhajuddin A, Gadad B, Greer T, Grannemann B, Soyombo A, et al. Can C-reactive protein inform antidepressant medication selection in depressed outpatients? Findings from the CO-MED trial. Psychoneuroendocrinology. 2017;78:105.

Pingault J-B, O’Reilly PF, Schoeler T, Ploubidis GB, Rijsdijk F, Dudbridge F. Using genetic data to strengthen causal inference in observational research. Nat Rev Genet. 2018;19:566–80.